Scientists Should Understand The Limitations As Well As The Virtues Of Citation Analysis

Two letters challenging the function and value of citation analysis arrived in my office recently, and I believe they merit a response for all of The Scientist's readers to ponder. Monitoring the scientific literature and developing statistics on the extent to which articles are referenced by subsequent authors have been consuming interests of mine for more than 30 years. I have consistently maintained that it is both intellectually worthwhile and professionally beneficial for scientists to und

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

One of the letters echoes a surprisingly widespread notion that citation analysis encourages mediocrity, or "consensus science." The writer asks: "If success is measured by citation analysis, won't scientists shy away from original and venturesome fields that don't produce strong citation records?" That is, will scientists abandon an exciting, potentially ground-breaking project or area of study that, when reported on, is unlikely to gain immediate attention from other researchers?

For responsible, intellectually honest scientists, the notion of statistics functioning as a determinant, rather than a reflection, of behavior is absurd. Of course, a few dubiously motivated researchers, hoping to grab in any way they can the attention of department heads or potential employers, will seek out any device that may enhance their name recognition and beef up their c.v.'s. But this is clearly an abuse of citation analysis. Blaming a measurement method for its abuses is like blaming a badly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies